chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Computerised tomogram abdomen normal, Computerised tomogram thorax normal, Cyanosis, Dizziness, Dyspepsia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Dysphagia, Epstein-Barr virus infection, Epstein-Barr virus test negative, Fatigue, Feeling cold
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Furuncle, Gait disturbance, Gout, Haematocrit normal, Haemoglobin normal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Headache, Heart rate decreased, Hepatitis C, Hepatitis C antibody positive, Hormone level abnormal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Hypoaesthesia, Hypoglycaemia, Hypotension, Hypothyroidism, Irritability
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Lymphadenopathy, Melanosis coli, Movement disorder, Muscle fatigue, Muscle spasms
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Muscular weakness, Musculoskeletal stiffness, Nausea, Orthopnoea, Pain
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Pain in extremity, Pallor, Pancreatitis, Pancytopenia, Platelet count decreased
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Pulse abnormal, Skin discolouration, Somnolence, Speech disorder, Spleen disorder
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Swelling face, Synovial cyst, Tachycardia, Thrombocytopenia, Tinnitus
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Urinary tract infection, Urinary tract infection, Vaccine positive rechallenge
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Abdominal distension, Abdominal pain upper, Agitation, Alopecia, Amenorrhoea
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Anaemia, Arthralgia, Asthenia, Autoimmune disorder, Cardiovascular insufficiency
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Constipation, Dizziness, Dyspepsia, Epstein-Barr virus infection, Fatigue
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Feeling cold, Gait disturbance, Gastrointestinal disorder, Headache, Hormone level abnormal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Hypokinesia, Hypotension, Hypothyroidism, Irritability, Laboratory test abnormal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Muscle fatigue, Muscle spasms, Muscular weakness, Nausea, Organ failure
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Orthopnoea, Pain, Pain in extremity, Pallor, Pancytopenia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Similar reaction on previous exposure to drug, Skin discolouration, Speech disorder, Swelling face, Thrombocytopenia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Tinnitus, Urinary tract infection, Vaccine positive rechallenge
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Abdominal pain, Alopecia, Amenorrhoea, Arrhythmia, Arthralgia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Asthenia, Autoimmune disorder, Blood pressure decreased, Body temperature decreased, Cardiovascular insufficiency
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Coeliac disease, Constipation, Dizziness, Face oedema, Fatigue
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act concerning a 17 year old female who on 13-MAR-2007 was vaccinated with a third dose of GARDASIL intramuscularly into the left arm. After the first dose of GARDASIL (administered on 13-SEP-2006) the patient experienced dizziness, light-headed, nauseous, headache, leg cramps and shooting leg pain. After the second dose of GARDASIL (administered on 13-NOV-2006) the patient experienced same symptoms after first dose plus hair loss, abdominal bloating, menstrual cycle stopped, weakness, poor circulation. After the third dose of GARDASIL the patient experienced all symptoms listed above plus excessive hair loss, pale/purple skin, always cold, loud ringing in ears, extreme digestive, stomach pain, gastrointestinal discomfort, chronic constipation, joint pain, facial swelling, chronic fatigue, irritability, easily agitated, extreme weakness and all-over muscle fatigue (with difficulty in walking, talking, moving, etc.) The patient was diagnosed with thrombocytopenia, pancytopenia, amenorrhea, hypothyroidism, anemia, low blood pressure, antoimmune disorder, partial organ failure, digestive disorder, Epstein Barre, orthopnoea, hormonal imbalance, urinary tract infection. The patient had to seek alternative medicine doctors to receive nutritional supplementation because other doctors could do nothing for her. Recently she has been referred to a clinic (Scheduled appointment for 30-Mar-2009). This was originally reported by a consumer. A standard lot check investigation was performed. All in-process quality checks for the lot number 0263U in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center and was released.